Francesco Freni

Dr. Francesco Freni

Department of Adult and Development Age Human Pathology “Gaetano Barresi”, unit of Otorhinolaryngology, University of Messina, 98168 Messina, Italy
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
FFFrancesco Freni
Francesco Freni
AMAlessandro Meduri
Alessandro Meduri
FGFrancesco Gazia
Francesco Gazia
VNViviana Nicastro
Viviana Nicastro
Cosimo GallettiCosimo Galletti
Cosimo Galletti
FGFrancesco Galletti
Francesco Galletti

21 April 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Cosimo GallettiCosimo Galletti
Cosimo Galletti
Maria Antonietta BarbieriMaria Antonietta Barbieri
Maria Antonietta Barbieri
FCFrancesco Ciodaro
Francesco Ciodaro
FFFrancesco Freni
Francesco Freni
FGFrancesco Gazia
Francesco Gazia
BGBruno Galletti
Bruno Galletti
Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a type 2 pattern of inflammation resulting in the production of some cytokines. Dupilumab radically changes the treatment of CRSwNP, but, considering its recent approval, it may be useful to evaluate its safety profile in a real-world setting. This work aimed to prospectively highlight the effectiveness and safety profile of dupilumab in patients with CRSwNP enrolled in the Otorhinolaryngology Unit of the University Hospital of Messina. An observational cohort study was carried out considering all patients treated with dupilumab. A descriptive analysis was conducted reporting all demographic characteristics, endoscopic evaluations, and symptom conditions. A total of 66 patients were treated with dupilumab, but three patients were excluded due to a lack of adherence during the observational period. A statistically significant reduction in the Sino-Nasal Outcome Test 22 (SNOT-22) and nasal polyps score (NPS) was shown at the 6th and 12th months compared to baseline values (SNOT-22, −37 and −50, p < 0.001 for both comparisons; NPS, −3 and −4, p < 0.001 for both comparisons). During the follow-up, eight patients (12.7%) had a reaction at the site of injection, and seven (11.1%) had transient hypereosinophilia. Given the optimal treatment response and the minimal adverse effects observed, clinicians should consider dupilumab a safe and effective treatment. Further studies are necessary to better understand the long-term effects.

1 October 2002 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
BGBruno Galletti
Bruno Galletti
SBSebastiano Bucolo
Sebastiano Bucolo
GAGiuseppe Abbate
Giuseppe Abbate
GCGiancarla Calabrese
Giancarla Calabrese
GRGiuseppe Romano
Giuseppe Romano
FFFrancesco Freni
Francesco Freni

22 August 2022 in Audiology Research
Verified
Journal Article
Open access
PDF file
Giacinto Asprella LibonatiGiacinto Asprella Libonati
Giacinto Asprella Libonati
ALantonello leone
antonello leone
Salvatore MartellucciSalvatore Martellucci
Salvatore Martellucci
AGAndrea Gallo
Andrea Gallo
RARoberto Albera
Roberto Albera
GGGiusi Graziano
Giusi Graziano
Benign paroxysmal positional vertigo (BPPV) usually has a favorable course, although it is possible to observe BPPV with a high recurrence rate. Previous studies suggested that vitamin D deficiency might affect BPPV recurrences, and oxidative stress might play a complementary role in BPPV pathogenesis. This multicentric trial aimed to evaluate the effectiveness of oral nutritional supplementation with a compound of alpha-lipoic acid, Carnosine, and Zinc (LICA® (Difass International, Coriano (RN), Italy)), vitamins of group B and vitamin D in preventing BPPV recurrences. A total of 128 patients with high recurrence-BPPV were randomized in three arms: Arm 1 consisted of subjects with “insufficient” or “deficient” vitamin D blood levels, treated with daily oral supplementation of LICA®, vitamins of group B and vitamin D3 (800 UI), Arm 2 included BPPV subjects with “sufficient” vitamin D who did not receive any nutritional support, and Arm 3 included subjects with a “sufficient” serum concentration of vitamin D who received supplementation with a compound of LICA® and Curcumin. After six months of follow-up, a significant reduction of BPPV relapses compared to the baseline was found only in Arm 1 (−2.32, 95% CI: 3.41–1.62, p-value < 0.0001). Study results suggested that oral nutritional supplementation with vitamin D3 plus antioxidants can prevent relapses in patients suffering from high recurrence-BPPV.

FFFrancesco Freni
Francesco Freni
FGFrancesco Gazia
Francesco Gazia
VSVictor Slavutsky
Victor Slavutsky
ESEnrique Perello Scherdel
Enrique Perello Scherdel
LNLuis Nicenboim
Luis Nicenboim
FGFrancesco Galletti
Francesco Galletti
The aim of the present study was to compare the posterior tympanotomy (PT) technique to the endomeatal approach. The endomeatal approach (EMA) for Cochlear Implant (CI) surgery was performed on 98 patients with procident lateral sinus or a small mastoid cavity, on 103 ears (Group A). Conventional mastoidectomy and PT was performed on the other 104 patients, on 107 ears (Group B). Data on all patients were then collected for the following: intra- and post-operative complications, Tinnitus Handicap Inventory (THI), Vertigo Symptom Scale (VSS), duration of surgery, and postoperative discomfort. The difference in the total number of major and minor complications between the case group and the control group was not statistically significant. There was a statistically significant difference in discomfort between the two groups using the Visual Analogue Scale (VAS), both immediately postsurgery (p = 0.02) and after one month (p = 0.04). The mean duration of surgery was 102 ± 29 min for EMA and 118 ± 15 min for the PT technique (p = 0.008). EMA is a faster technique resulting in reduced postoperative patient discomfort in comparison to the PT method. The experience of the surgeon as well as the correct choice of surgical technique are fundamental to successful outcomes for cochlear implant surgery.

1 November 2012 in Journal of Voice
Verified
Journal Article
Closed access
BGBruno Galletti
Bruno Galletti
FFFrancesco Freni
Francesco Freni
Giovanni CammarotoGiovanni Cammaroto
Giovanni Cammaroto
NCNatalia Catalano
Natalia Catalano
GGGiovanna Gangemi
Giovanna Gangemi
FGFrancesco Galletti
Francesco Galletti